Iamgold Corporation Ordinary Shares And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

(VIANEWS) – Iamgold Corporation Ordinary Shares (IAG), CONMED Corporation (CNMD), Itron (ITRI) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Iamgold Corporation Ordinary Shares (IAG)

69.7% sales growth and 4.36% return on equity

IAMGOLD Corporation, through its subsidiaries, explores, develops, and operates gold mining properties in North America, South America, and West Africa. The company owns interests in the Rosebel mine located in Suriname, South America; the Essakane mine situated in Burkina Faso and Boto gold project located in Senegal, West Africa; and Westwood mine, covers an area of 1,925 hectare and located in Quebec and the Côté gold project, which covers an area of 586 square kilometer located in Ontario, Canada. Its exploration and development projects include the Pitangui project in Brazil; the Karita project located in Guinea; the Diakha-Siribaya project situated in Mali; and the Nelligan and Monster Lake projects located in Quebec, Canada. IAMGOLD Corporation was incorporated in 1990 and is headquartered in Toronto, Canada.

Earnings Per Share

As for profitability, Iamgold Corporation Ordinary Shares has a trailing twelve months EPS of $0.18.

PE Ratio

Iamgold Corporation Ordinary Shares has a trailing twelve months price to earnings ratio of 19.39. Meaning, the purchaser of the share is investing $19.39 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.36%.

Volume

Today’s last reported volume for Iamgold Corporation Ordinary Shares is 12202700 which is 30.61% above its average volume of 9342440.

Sales Growth

Iamgold Corporation Ordinary Shares’s sales growth is 33.2% for the ongoing quarter and 69.7% for the next.

Revenue Growth

Year-on-year quarterly revenue growth grew by 43.6%, now sitting on 987.1M for the twelve trailing months.

2. CONMED Corporation (CNMD)

11.7% sales growth and 8.16% return on equity

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for minimally invasive procedures worldwide. It offers orthopedic surgery products, including sports medicine products comprising powered resection instruments, arthroscopes, reconstructive systems, tissue repair sets, and metal and bioabsorbable implants, as well as related disposable products and fluid management systems; powered surgical instruments for use in bone orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries; sports biologics and tissue products; and surgical visualization products. The company markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also offers general surgery products, such as clinical insufflation, smoke evacuation, electrosurgical, and endomechanical products; and endoscopic technologies, including diagnostic and therapeutic products for use in gastroenterology procedures, and products for the treatment of diseases of the biliary structures, as well as cardiac monitoring products comprising ECG and EEG electrodes, and cardiac defibrillation pads. The company markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.

Earnings Per Share

As for profitability, CONMED Corporation has a trailing twelve months EPS of $2.04.

PE Ratio

CONMED Corporation has a trailing twelve months price to earnings ratio of 39.42. Meaning, the purchaser of the share is investing $39.42 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.16%.

Sales Growth

CONMED Corporation’s sales growth for the next quarter is 11.7%.

Growth Estimates Quarters

The company’s growth estimates for the current quarter and the next is 12.1% and 16.9%, respectively.

Yearly Top and Bottom Value

CONMED Corporation’s stock is valued at $80.42 at 16:22 EST, way under its 52-week high of $138.47 and higher than its 52-week low of $74.67.

3. Itron (ITRI)

7.9% sales growth and 7.79% return on equity

Itron, Inc., a technology and service company, provides end-to-end solutions that help manage operations in the energy, water, and smart city space worldwide. It operates through three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing. The Networked Solutions segment provides a combination of communicating devices, such as smart meters, modules, endpoints, and sensors; network infrastructure; and associated application software for acquiring and transporting application-specific data. The Outcomes segment offers value-added, enhanced software and services for managing, organizing, analyzing, and interpreting data to enhance decision making, maximize operational profitability, drive resource efficiency, and deliver results for consumers, utilities, and smart cities. In addition, it offers implementation, project management, installation, consulting, and post-sale maintenance support services, as well as cloud and software-as-a-service; and extended or customer-specific warranties. It offers its products and services under the Itron brand. The company markets its products directly through its sales force, as well as through indirect sales force consisting of distributors, agents, partners, and meter manufacturer representatives to utilities and municipalities. Itron, Inc. was incorporated in 1977 and is headquartered in Liberty Lake, Washington.

Earnings Per Share

As for profitability, Itron has a trailing twelve months EPS of $2.11.

PE Ratio

Itron has a trailing twelve months price to earnings ratio of 42.88. Meaning, the purchaser of the share is investing $42.88 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.79%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Itron’s EBITDA is 56.35.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is 71.4% and 30.8%, respectively.

Revenue Growth

Year-on-year quarterly revenue growth grew by 23.5%, now sitting on 2.17B for the twelve trailing months.

4. Southern Copper (SCCO)

5.3% sales growth and 31.16% return on equity

Southern Copper Corporation engages in mining, exploring, smelting, and refining copper and other minerals in Peru, Mexico, Argentina, Ecuador, and Chile. The company is involved in the mining, milling, and flotation of copper ore to produce copper and molybdenum concentrates; smelting of copper concentrates to produce blister and anode copper; refining of anode copper to produce copper cathodes; production of molybdenum concentrate and sulfuric acid; production of refined silver, gold, and other materials; and mining and processing of zinc, copper, molybdenum, silver, gold, and lead. It operates the Toquepala and Cuajone open-pit mines, and a smelter and refinery in Peru; and La Caridad, an open-pit copper mine, as well as a copper ore concentrator, a SX-EW plant, a smelter, refinery, and a rod plant in Mexico. The company also operates Buenavista, an open-pit copper mine, as well as two copper concentrators and two operating SX-EW plants in Mexico. In addition, it operates underground mines that produce zinc, lead, copper, silver, and gold; a coal mine; and a zinc refinery. The company has interests in 156,818 hectares and 502,688 hectares of concessions in Peru and Mexico; and 168,200 hectares and 28,453 hectares of exploration concessions in Argentina and Chile. Southern Copper Corporation was incorporated in 1952 and is based in Phoenix, Arizona. Southern Copper Corporation operates as a subsidiary of Americas Mining Corporation.

Earnings Per Share

As for profitability, Southern Copper has a trailing twelve months EPS of $3.13.

PE Ratio

Southern Copper has a trailing twelve months price to earnings ratio of 36.82. Meaning, the purchaser of the share is investing $36.82 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 31.16%.

Moving Average

Southern Copper’s value is way above its 50-day moving average of $96.14 and way higher than its 200-day moving average of $82.50.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter is a negative 29.5% and positive 15.5% for the next.

Revenue Growth

Year-on-year quarterly revenue growth declined by 18.6%, now sitting on 9.9B for the twelve trailing months.

Dividend Yield

As maintained by Morningstar, Inc., the next dividend payment is on Feb 12, 2024, the estimated forward annual dividend rate is 3.2 and the estimated forward annual dividend yield is 2.82%.

Leave a Reply

Your email address will not be published. Required fields are marked *